| Platelet interaction with innate immune cells JB Kral, WC Schrottmaier, M Salzmann, A Assinger Transfusion Medicine and Hemotherapy 43 (2), 78-88, 2016 | 266 | 2016 |
| Platelets in sepsis: an update on experimental models and clinical data A Assinger, WC Schrottmaier, M Salzmann, J Rayes Frontiers in immunology 10, 459996, 2019 | 211 | 2019 |
| Platelets mediate oxidized low-density lipoprotein–induced monocyte extravasation and foam cell formation S Badrnya, WC Schrottmaier, JB Kral, KC Yaiw, I Volf, G Schabbauer, ... Arteriosclerosis, thrombosis, and vascular biology 34 (3), 571-580, 2014 | 194 | 2014 |
| Measuring and interpreting platelet-leukocyte aggregates M Finsterbusch, WC Schrottmaier, JB Kral-Pointner, M Salzmann, ... Platelets 29 (7), 677-685, 2018 | 163 | 2018 |
| Aspirin and P2Y12 Inhibitors in platelet-mediated activation of neutrophils and monocytes WC Schrottmaier, JB Kral, S Badrnya, A Assinger Thrombosis and haemostasis 114 (09), 478-789, 2015 | 150 | 2015 |
| Macrophage PTEN regulates expression and secretion of arginase I modulating innate and adaptive immune responses E Sahin, S Haubenwallner, M Kuttke, I Kollmann, A Halfmann, AB Dohnal, ... The Journal of Immunology 193 (4), 1717-1727, 2014 | 142 | 2014 |
| Up‐regulation of the fibroblast growth factor 8 subfamily in human hepatocellular carcinoma for cell survival and neoangiogenesis C Gauglhofer, S Sagmeister, W Schrottmaier, C Fischer, ... Hepatology 53 (3), 854-864, 2011 | 130 | 2011 |
| Platelet-leukocyte interplay during vascular disease WC Schrottmaier, M Mussbacher, M Salzmann, A Assinger Atherosclerosis 307, 109-120, 2020 | 120 | 2020 |
| Human Cytomegalovirus–platelet interaction triggers toll-like receptor 2–dependent proinflammatory and proangiogenic responses A Assinger, JB Kral, KC Yaiw, WC Schrottmaier, E Kurzejamska, Y Wang, ... Arteriosclerosis, thrombosis, and vascular biology 34 (4), 801-809, 2014 | 117 | 2014 |
| Sustained PI3K Activation exacerbates BLM-induced Lung Fibrosis via activation of pro-inflammatory and pro-fibrotic pathways JB Kral, M Kuttke, WC Schrottmaier, B Birnecker, J Warszawska, C Wernig, ... Scientific reports 6 (1), 23034, 2016 | 83 | 2016 |
| The profile of platelet α‐granule released molecules affects postoperative liver regeneration P Starlinger, S Haegele, F Offensperger, L Oehlberger, D Pereyra, JB Kral, ... Hepatology 63 (5), 1675-1688, 2016 | 79 | 2016 |
| Optimized plasma preparation is essential to monitor platelet-stored molecules in humans M Mussbacher, WC Schrottmaier, M Salzmann, C Brostjan, JA Schmid, ... PLoS One 12 (12), e0188921, 2017 | 60 | 2017 |
| Fibroblast growth factor receptor 4: A putative key driver for the aggressive phenotype of hepatocellular carcinoma C Gauglhofer, J Paur, WC Schrottmaier, B Wingelhofer, D Huber, ... Carcinogenesis 35 (10), 2331-2338, 2014 | 44 | 2014 |
| Fibroblast growth factor receptor 3 isoforms: Novel therapeutic targets for hepatocellular carcinoma? J Paur, L Nika, C Maier, A Moscu‐Gregor, J Kostka, D Huber, T Mohr, ... Hepatology 62 (6), 1767-1778, 2015 | 41 | 2015 |
| S100A8/A9 drives the formation of procoagulant platelets through GPIbα M Colicchia, WC Schrottmaier, G Perrella, JS Reyat, J Begum, A Slater, ... Blood, The Journal of the American Society of Hematology 140 (24), 2626-2643, 2022 | 31 | 2022 |
| Low-molecular-weight heparin use in coronavirus disease 2019 is associated with curtailed viral persistence: a retrospective multicentre observational study D Pereyra, S Heber, WC Schrottmaier, J Santol, A Pirabe, ... Cardiovascular research 117 (14), 2807-2820, 2021 | 28 | 2021 |
| Platelet phenotype analysis of COVID-19 patients reveals progressive changes in the activation of integrin αIIbβ3, F13A1, the SARS-CoV-2 Target EIF4A1 and Annexin A5 H Ercan, WC Schrottmaier, A Pirabe, A Schmuckenschlager, D Pereyra, ... Frontiers in cardiovascular medicine 8, 779073, 2021 | 27 | 2021 |
| Impact of anticoagulation and sample processing on the quantification of human blood-derived microRNA signatures M Mussbacher, TL Krammer, S Heber, WC Schrottmaier, S Zeibig, ... Cells 9 (8), 1915, 2020 | 26 | 2020 |
| Comparison of patient intake of ticagrelor, prasugrel, or clopidogrel on restoring platelet function by donor platelets G Scharbert, L Wetzel, WC Schrottmaier, JB Kral, T Weber, A Assinger Transfusion 55 (6), 1320-1326, 2015 | 25 | 2015 |
| Platelet activation at the onset of human endotoxemia is undetectable in vivo WC Schrottmaier, JB Kral, M Zeitlinger, M Salzmann, B Jilma, A Assinger Platelets 27 (5), 479-483, 2016 | 24 | 2016 |
